Table 2.
Distribution of morphologic variants in HMC across both hemispheres in glioma patients.
| Right |
Total | |||||
|---|---|---|---|---|---|---|
| Ω | ε | Ω-ε | ε-Ω | |||
| Left | Ω | 128 (46.4) | 21 (7.6) | 4 (1.4) | 0 (0.0) | 153 (55.4) |
| ε | 17 (6.2) | 58 (21.0) | 2 (0.7) | 0 (0.0) | 77 (27.9) | |
| Ω-ε | 13 (4.7) | 7 (2.5) | 23 (8.4) | 0 (0.0) | 43 (15.6) | |
| ε-Ω | 2 (0.7) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 3 (1.1) | |
| Total | 160 (58.0) | 87 (31.5) | 29 (10.5) | 0 (0.0) | 276 | |
No significant difference was observed in the incidence of morphological variants of HMC across bilateral cerebral hemispheres (p = 0.0901, Chi-square test).
The morphology of HMC in bilateral cerebral hemispheres demonstrated consistency (p < 0.0001, Kappa test).